IBDSpot™
A breakthrough in treating inflammation in the inflammatory bowel disease domain.
Revolutionizing Regenerative Medicine
Organoid Solutions
Central to the Cell2Cure ecosystem lies Organoid Solutions, a pioneering force in the field of regenerative medicine. Specializing in conceiving, manufacturing, and rigorously testing patented, state-of-the-art products that are poised to reshape the very essence of healthcare standards.
Modes of
Organoid Solutions
- Utilizes licensed exosomes derived from intestinal organoids.
- A non-toxic, non-pharma solution available in oral form.
- Positioned to be a strong alternative to biologics.
- A unique blend of immune cells tailored for organoid co-culturing.
- Produces ‘licensed’ organoids that secrete ‘licensed-exosomes’. The immune cell concentration varies based on the organoid source.
- A novel approach to organ transplantation.
- Uses licensed exosomes from co-cultured donor and recipient organoids with A2 Cells.
- Delivered orally, it aims to protect the new organ, minimizing the need for heavy immunosuppression.
- A visionary solution for Diabetes management.
- Uses licensed exosomes from pancreatic spheroids co-cultured with A2cells.
- Can be taken orally, trans-dermally, or intraocularly, paving the way for optimal glucose homeostasis.